The complete contraindication list lives in the FDA label
Procedures including Roux-en-Y gastric bypass, sleeve gastrectomy, and adjustable gastric banding produce 20-35% total body weight loss and significant improvement in obesity-related comorbidities including type 2 diabetes, hypertension, and obstructive sleep apnea
In a head-to-head study involving diabetes patients, orforglipron outperformed Novo's oral semaglutide (Rybelsus) in A1C reduction and achieved greater weight loss (9.2% versus 5.3% body weight reduction)
Emerging data has led many patients and healthcare providers to compare Trulicity with Ozempic and Mounjaro when evaluating safety risks
How long you should stay on semaglutide depends on your goals, your ability to maintain lifestyle changes, and your provider's recommendations
vomiting blood or coffee-ground material